YHB Investment Advisors Inc. Cuts Holdings in Colgate-Palmolive (NYSE:CL)

YHB Investment Advisors Inc. reduced its holdings in Colgate-Palmolive (NYSE:CL) by 6.6% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 16,090 shares of the company’s stock after selling 1,146 shares during the quarter. YHB Investment Advisors Inc.’s holdings in Colgate-Palmolive were worth $1,670,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. Diversify Advisory Services LLC acquired a new position in Colgate-Palmolive during the first quarter worth about $911,000. TD Asset Management Inc increased its stake in Colgate-Palmolive by 2.4% in the 1st quarter. TD Asset Management Inc now owns 1,154,566 shares of the company’s stock valued at $103,969,000 after purchasing an additional 26,987 shares in the last quarter. Empowered Funds LLC raised its holdings in Colgate-Palmolive by 277.3% during the first quarter. Empowered Funds LLC now owns 33,082 shares of the company’s stock worth $2,979,000 after purchasing an additional 24,314 shares during the last quarter. M&G Plc purchased a new stake in Colgate-Palmolive during the first quarter worth $3,812,000. Finally, Sei Investments Co. grew its holdings in Colgate-Palmolive by 41.5% in the first quarter. Sei Investments Co. now owns 598,639 shares of the company’s stock valued at $53,901,000 after purchasing an additional 175,445 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. Sanford C. Bernstein boosted their price objective on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a research report on Tuesday, July 30th. Piper Sandler started coverage on shares of Colgate-Palmolive in a report on Tuesday, September 24th. They issued an “overweight” rating and a $121.00 price target on the stock. Morgan Stanley raised their price objective on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a research note on Monday, July 29th. Jefferies Financial Group lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their target price for the company from $103.00 to $95.00 in a research note on Wednesday, July 24th. Finally, TD Cowen raised their price target on Colgate-Palmolive from $110.00 to $115.00 and gave the stock a “buy” rating in a research report on Tuesday, July 30th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $106.00.

Insider Transactions at Colgate-Palmolive

In related news, insider Sally Massey sold 15,850 shares of the firm’s stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the transaction, the insider now owns 13,942 shares in the company, valued at approximately $1,439,929.76. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the firm’s stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the transaction, the insider now directly owns 13,942 shares of the company’s stock, valued at $1,439,929.76. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Panagiotis Tsourapas sold 14,794 shares of the business’s stock in a transaction dated Thursday, August 8th. The stock was sold at an average price of $102.94, for a total value of $1,522,894.36. Following the transaction, the insider now owns 5,146 shares in the company, valued at approximately $529,729.24. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 43,490 shares of company stock worth $4,486,063. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $98.98 on Thursday. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.70 and a current ratio of 1.06. The firm has a market capitalization of $81.21 billion, a price-to-earnings ratio of 31.32, a price-to-earnings-growth ratio of 3.54 and a beta of 0.40. Colgate-Palmolive has a one year low of $71.46 and a one year high of $109.30. The company has a 50 day moving average price of $103.31 and a 200 day moving average price of $97.84.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, July 26th. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The business had revenue of $5.06 billion during the quarter, compared to the consensus estimate of $5 billion. During the same period in the prior year, the firm posted $0.77 EPS. The business’s revenue for the quarter was up 4.9% on a year-over-year basis. Sell-side analysts anticipate that Colgate-Palmolive will post 3.57 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.02%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.